This study was designed to evaluate the effect of Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms on MTX toxicity in pediatric Egyptian ALL patients. The gene discussed is MTHFR; the disease is acute lymphoblastic leukemia.